Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiwerth

Showing results (201-210 of 321) with videos related to

Pageof 33
Sort By:
European Journal of Pharmacology|February 4, 2014
Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administrationBozidar Duplancic, Vasilije Stambolija, Jadranka Holjevac, et al.
European Journal of Pharmacology|April 10, 2016
BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmiasVasilije Stambolija, Tamara Perleta Stambolija, Jadranka Katancic Holjevac, et al.
Current Pharmaceutical Design|February 24, 2017
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Behavioural Brain Research|September 21, 2020
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophreniaAndrea Zemba Cilic, Mladen Zemba, Matija Cilic, et al.
Acta Clinica Croatica|June 28, 2021
Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in ratsIvan Mirković, Tamara Kralj, Marin Lozić, et al.
Croatian Medical Journal|July 5, 2016
High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host diseaseRomana Čeović, Lana Desnica, Dražen Pulanić, et al.
Surgery Today|August 24, 2007
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the ratTihomir Vuksic, Ivan Zoricic, Luka Brcic, et al.
Current Medicinal Chemistry|February 4, 2012
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157P Sikiric, S Seiwerth, R Rucman, et al.
Life Sciences|August 12, 2017
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in ratsDean Strinic, Zeljka Belosic Halle, Kresimir Luetic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pageof 33

Showing results (201-210 of 321) with videos related to

Sort By:
Pageof 33
European Journal of Pharmacology|February 4, 2014
Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administrationBozidar Duplancic, Vasilije Stambolija, Jadranka Holjevac, et al.
European Journal of Pharmacology|April 10, 2016
BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmiasVasilije Stambolija, Tamara Perleta Stambolija, Jadranka Katancic Holjevac, et al.
Current Pharmaceutical Design|February 24, 2017
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?Predrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Behavioural Brain Research|September 21, 2020
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophreniaAndrea Zemba Cilic, Mladen Zemba, Matija Cilic, et al.
Acta Clinica Croatica|June 28, 2021
Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in ratsIvan Mirković, Tamara Kralj, Marin Lozić, et al.
Croatian Medical Journal|July 5, 2016
High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host diseaseRomana Čeović, Lana Desnica, Dražen Pulanić, et al.
Surgery Today|August 24, 2007
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the ratTihomir Vuksic, Ivan Zoricic, Luka Brcic, et al.
Current Medicinal Chemistry|February 4, 2012
Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157P Sikiric, S Seiwerth, R Rucman, et al.
Life Sciences|August 12, 2017
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in ratsDean Strinic, Zeljka Belosic Halle, Kresimir Luetic, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. <i>Pharmaceuticals</i> 2025, <i>18</i>, 185Predrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pageof 33